Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion type Assertion NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_head.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion description "[Overall and cancer-specific survival rates of patients with ESCC with high LOX expression were significantly lower than those of patients with ESCC with low LOX expression (P = 0.024 and P = 0.012).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_provenance.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion evidence source_evidence_literature NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_provenance.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion SIO_000772 19526206 NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_provenance.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion wasDerivedFrom befree-20140225 NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_provenance.
- NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_assertion wasGeneratedBy ECO_0000203 NP239365.RAY2dmIJS6fTBhwK6yIpnZvJGjHuBjKsa4pZYbGzcNF1w130_provenance.